Point-Of-Care Or Rapid Diagnostics Industry Research Report 2023
Point-of-care testing (POCT or bedside testing) is defined as medical diagnostic testing at or near the point of care—that is, at the time and place of patient care.
In our report, blood glucose test strips and blood glucose meter, which mainly used at home, are not included.
Highlights
The global Point-Of-Care Or Rapid Diagnostics market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
In Spain & Portugal Market, Oint-of-Care or Rapid Diagnostics key players include, Roche, Abbott, Danaher, Siemens Healthcare, Bio-Rad Laboratories, etc. Top 5 manufacturers hold a share over 74%.
In terms of product, Intensive Care is the largest segment, with a share over 19%. And in terms of application, the largest application is Hospital, followed by Clinic, Independent Laboratories and Others.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Point-Of-Care Or Rapid Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Point-Of-Care Or Rapid Diagnostics.
The Point-Of-Care Or Rapid Diagnostics market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Point-Of-Care Or Rapid Diagnostics market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Point-Of-Care Or Rapid Diagnostics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Roche
Abbott
Danaher
Siemens Healthcare
Bio-Rad Laboratories
BioMerieux
Nova Biomedical
Thermo Fisher Scientific
Quidel
A. Menarini Diagnostics
Becton Dickinson
Biosurfit
Astrego Diagnostics
Werfen
Abionic
Palex Medical/Bülhmann
Horiba Medical
RAL
Vircell
Monlab
Binding Site
Product Type Insights
Global markets are presented by Point-Of-Care Or Rapid Diagnostics type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Point-Of-Care Or Rapid Diagnostics are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Point-Of-Care Or Rapid Diagnostics segment by Type
Intensive Care
Covid-19 Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Others
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Point-Of-Care Or Rapid Diagnostics market and what implications these may have on the industrys future. This report can help to understand the relevant market and consumer trends that are driving the Point-Of-Care Or Rapid Diagnostics market.
Point-Of-Care Or Rapid Diagnostics segment by Application
Hospital
Clinic
Independent Laboratories
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Point-Of-Care Or Rapid Diagnostics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Point-Of-Care Or Rapid Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Point-Of-Care Or Rapid Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Point-Of-Care Or Rapid Diagnostics industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Point-Of-Care Or Rapid Diagnostics.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Point-Of-Care Or Rapid Diagnostics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Point-Of-Care Or Rapid Diagnostics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Point-Of-Care Or Rapid Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Frequently Asked Questions
Which product segment grabbed the largest share in the Product Name market?
How is the competitive scenario of the Product Name market?
Which are the key factors aiding the Product Name market growth?
Which are the prominent players in the Product Name market?
Which region holds the maximum share in the Product Name market?
What will be the CAGR of the Product Name market during the forecast period?
Which application segment emerged as the leading segment in the Product Name market?
What key trends are likely to emerge in the Product Name market in the coming years?
What will be the Product Name market size by 2028?
Which company held the largest share in the Product Name market?
In our report, blood glucose test strips and blood glucose meter, which mainly used at home, are not included.
Highlights
The global Point-Of-Care Or Rapid Diagnostics market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
In Spain & Portugal Market, Oint-of-Care or Rapid Diagnostics key players include, Roche, Abbott, Danaher, Siemens Healthcare, Bio-Rad Laboratories, etc. Top 5 manufacturers hold a share over 74%.
In terms of product, Intensive Care is the largest segment, with a share over 19%. And in terms of application, the largest application is Hospital, followed by Clinic, Independent Laboratories and Others.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Point-Of-Care Or Rapid Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Point-Of-Care Or Rapid Diagnostics.
The Point-Of-Care Or Rapid Diagnostics market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Point-Of-Care Or Rapid Diagnostics market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Point-Of-Care Or Rapid Diagnostics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Roche
Abbott
Danaher
Siemens Healthcare
Bio-Rad Laboratories
BioMerieux
Nova Biomedical
Thermo Fisher Scientific
Quidel
A. Menarini Diagnostics
Becton Dickinson
Biosurfit
Astrego Diagnostics
Werfen
Abionic
Palex Medical/Bülhmann
Horiba Medical
RAL
Vircell
Monlab
Binding Site
Product Type Insights
Global markets are presented by Point-Of-Care Or Rapid Diagnostics type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Point-Of-Care Or Rapid Diagnostics are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Point-Of-Care Or Rapid Diagnostics segment by Type
Intensive Care
Covid-19 Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Others
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Point-Of-Care Or Rapid Diagnostics market and what implications these may have on the industrys future. This report can help to understand the relevant market and consumer trends that are driving the Point-Of-Care Or Rapid Diagnostics market.
Point-Of-Care Or Rapid Diagnostics segment by Application
Hospital
Clinic
Independent Laboratories
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Point-Of-Care Or Rapid Diagnostics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Point-Of-Care Or Rapid Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Point-Of-Care Or Rapid Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Point-Of-Care Or Rapid Diagnostics industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Point-Of-Care Or Rapid Diagnostics.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Point-Of-Care Or Rapid Diagnostics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Point-Of-Care Or Rapid Diagnostics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Point-Of-Care Or Rapid Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Frequently Asked Questions
Which product segment grabbed the largest share in the Product Name market?
How is the competitive scenario of the Product Name market?
Which are the key factors aiding the Product Name market growth?
Which are the prominent players in the Product Name market?
Which region holds the maximum share in the Product Name market?
What will be the CAGR of the Product Name market during the forecast period?
Which application segment emerged as the leading segment in the Product Name market?
What key trends are likely to emerge in the Product Name market in the coming years?
What will be the Product Name market size by 2028?
Which company held the largest share in the Product Name market?
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Point-Of-Care Or Rapid Diagnostics Market Size (2018-2029) & (US$ Million)
2.2.2 Global Point-Of-Care Or Rapid Diagnostics Sales (2018-2029)
2.2.3 Global Point-Of-Care Or Rapid Diagnostics Market Average Price (2018-2029)
2.3 Point-Of-Care Or Rapid Diagnostics by Type
2.3.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 Intensive Care
1.2.3 Covid-19 Testing
1.2.4 Infectious Diseases Testing
1.2.5 Cardiac Markers Testing
1.2.6 Coagulation Testing
1.2.7 Others
2.4 Point-Of-Care Or Rapid Diagnostics by Application
2.4.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
2.4.2 Hospital
2.4.3 Clinic
2.4.4 Independent Laboratories
2.4.5 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Point-Of-Care Or Rapid Diagnostics Market Competitive Situation by Manufacturers (2018 Versus 2022)
3.2 Global Point-Of-Care Or Rapid Diagnostics Sales (K Doses) of Manufacturers (2018-2023)
3.3 Global Point-Of-Care Or Rapid Diagnostics Revenue of Manufacturers (2018-2023)
3.4 Global Point-Of-Care Or Rapid Diagnostics Average Price by Manufacturers (2018-2023)
3.5 Global Point-Of-Care Or Rapid Diagnostics Industry Ranking, 2021 VS 2022 VS 2023
3.6 Global Manufacturers of Point-Of-Care Or Rapid Diagnostics, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Point-Of-Care Or Rapid Diagnostics, Product Type & Application
3.8 Global Manufacturers of Point-Of-Care Or Rapid Diagnostics, Date of Enter into This Industry
3.9 Global Point-Of-Care Or Rapid Diagnostics Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Roche
4.1.1 Roche Company Information
4.1.2 Roche Business Overview
4.1.3 Roche Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
4.1.4 Roche Point-Of-Care Or Rapid Diagnostics Product Portfolio
4.1.5 Roche Recent Developments
4.2 Abbott
4.2.1 Abbott Company Information
4.2.2 Abbott Business Overview
4.2.3 Abbott Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
4.2.4 Abbott Point-Of-Care Or Rapid Diagnostics Product Portfolio
4.2.5 Abbott Recent Developments
4.3 Danaher
4.3.1 Danaher Company Information
4.3.2 Danaher Business Overview
4.3.3 Danaher Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
4.3.4 Danaher Point-Of-Care Or Rapid Diagnostics Product Portfolio
4.3.5 Danaher Recent Developments
4.4 Siemens Healthcare
4.4.1 Siemens Healthcare Company Information
4.4.2 Siemens Healthcare Business Overview
4.4.3 Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
4.4.4 Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Product Portfolio
4.4.5 Siemens Healthcare Recent Developments
4.5 Bio-Rad Laboratories
4.5.1 Bio-Rad Laboratories Company Information
4.5.2 Bio-Rad Laboratories Business Overview
4.5.3 Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.5.5 Bio-Rad Laboratories Recent Developments
4.6 BioMerieux
4.6.1 BioMerieux Company Information
4.6.2 BioMerieux Business Overview
4.6.3 BioMerieux Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
4.6.4 BioMerieux Point-Of-Care Or Rapid Diagnostics Product Portfolio
4.6.5 BioMerieux Recent Developments
4.7 Nova Biomedical
4.7.1 Nova Biomedical Company Information
4.7.2 Nova Biomedical Business Overview
4.7.3 Nova Biomedical Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
4.7.4 Nova Biomedical Point-Of-Care Or Rapid Diagnostics Product Portfolio
4.7.5 Nova Biomedical Recent Developments
6.8 Thermo Fisher Scientific
4.8.1 Thermo Fisher Scientific Company Information
4.8.2 Thermo Fisher Scientific Business Overview
4.8.3 Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
4.8.4 Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Product Portfolio
4.8.5 Thermo Fisher Scientific Recent Developments
4.9 Quidel
4.9.1 Quidel Company Information
4.9.2 Quidel Business Overview
4.9.3 Quidel Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
4.9.4 Quidel Point-Of-Care Or Rapid Diagnostics Product Portfolio
4.9.5 Quidel Recent Developments
4.10 A. Menarini Diagnostics
4.10.1 A. Menarini Diagnostics Company Information
4.10.2 A. Menarini Diagnostics Business Overview
4.10.3 A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
4.10.4 A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Product Portfolio
4.10.5 A. Menarini Diagnostics Recent Developments
6.11 Becton Dickinson
6.11.1 Becton Dickinson Company Information
6.11.2 Becton Dickinson Point-Of-Care Or Rapid Diagnostics Business Overview
6.11.3 Becton Dickinson Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Becton Dickinson Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.11.5 Becton Dickinson Recent Developments
6.12 Biosurfit
6.12.1 Biosurfit Company Information
6.12.2 Biosurfit Point-Of-Care Or Rapid Diagnostics Business Overview
6.12.3 Biosurfit Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Biosurfit Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.12.5 Biosurfit Recent Developments
6.13 Astrego Diagnostics
6.13.1 Astrego Diagnostics Company Information
6.13.2 Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Business Overview
6.13.3 Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.13.5 Astrego Diagnostics Recent Developments
6.14 Werfen
6.14.1 Werfen Company Information
6.14.2 Werfen Point-Of-Care Or Rapid Diagnostics Business Overview
6.14.3 Werfen Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Werfen Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.14.5 Werfen Recent Developments
6.15 Abionic
6.15.1 Abionic Company Information
6.15.2 Abionic Point-Of-Care Or Rapid Diagnostics Business Overview
6.15.3 Abionic Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Abionic Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.15.5 Abionic Recent Developments
6.16 Palex Medical/Bülhmann
6.16.1 Palex Medical/Bülhmann Company Information
6.16.2 Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Business Overview
6.16.3 Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.16.5 Palex Medical/Bülhmann Recent Developments
6.17 Horiba Medical
6.17.1 Horiba Medical Company Information
6.17.2 Horiba Medical Point-Of-Care Or Rapid Diagnostics Business Overview
6.17.3 Horiba Medical Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Horiba Medical Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.17.5 Horiba Medical Recent Developments
6.18 RAL
6.18.1 RAL Company Information
6.18.2 RAL Point-Of-Care Or Rapid Diagnostics Business Overview
6.18.3 RAL Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
6.18.4 RAL Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.18.5 RAL Recent Developments
6.19 Vircell
6.19.1 Vircell Company Information
6.19.2 Vircell Point-Of-Care Or Rapid Diagnostics Business Overview
6.19.3 Vircell Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Vircell Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.19.5 Vircell Recent Developments
6.20 Monlab
6.20.1 Monlab Company Information
6.20.2 Monlab Point-Of-Care Or Rapid Diagnostics Business Overview
6.20.3 Monlab Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Monlab Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.20.5 Monlab Recent Developments
6.21 Binding Site
6.21.1 Binding Site Company Information
6.21.2 Binding Site Point-Of-Care Or Rapid Diagnostics Business Overview
6.21.3 Binding Site Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
6.21.4 Binding Site Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.21.5 Binding Site Recent Developments
5 Global Point-Of-Care Or Rapid Diagnostics Market Scenario by Region
5.1 Global Point-Of-Care Or Rapid Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Point-Of-Care Or Rapid Diagnostics Sales by Region: 2018-2029
5.2.1 Global Point-Of-Care Or Rapid Diagnostics Sales by Region: 2018-2023
5.2.2 Global Point-Of-Care Or Rapid Diagnostics Sales by Region: 2024-2029
5.3 Global Point-Of-Care Or Rapid Diagnostics Revenue by Region: 2018-2029
5.3.1 Global Point-Of-Care Or Rapid Diagnostics Revenue by Region: 2018-2023
5.3.2 Global Point-Of-Care Or Rapid Diagnostics Revenue by Region: 2024-2029
5.4 North America Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Country
5.4.1 North America Point-Of-Care Or Rapid Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
5.4.2 North America Point-Of-Care Or Rapid Diagnostics Sales by Country (2018-2029)
5.4.3 North America Point-Of-Care Or Rapid Diagnostics Revenue by Country (2018-2029)
5.4.4 United States
5.4.5 Canada
5.5 Europe Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Country
5.5.1 Europe Point-Of-Care Or Rapid Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
5.5.2 Europe Point-Of-Care Or Rapid Diagnostics Sales by Country (2018-2029)
5.5.3 Europe Point-Of-Care Or Rapid Diagnostics Revenue by Country (2018-2029)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Country
5.6.1 Asia Pacific Point-Of-Care Or Rapid Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
5.6.2 Asia Pacific Point-Of-Care Or Rapid Diagnostics Sales by Country (2018-2029)
5.6.3 Asia Pacific Point-Of-Care Or Rapid Diagnostics Revenue by Country (2018-2029)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Country
5.7.1 Latin America Point-Of-Care Or Rapid Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
5.7.2 Latin America Point-Of-Care Or Rapid Diagnostics Sales by Country (2018-2029)
5.7.3 Latin America Point-Of-Care Or Rapid Diagnostics Revenue by Country (2018-2029)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Country
5.8.1 Middle East and Africa Point-Of-Care Or Rapid Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
5.8.2 Middle East and Africa Point-Of-Care Or Rapid Diagnostics Sales by Country (2018-2029)
5.8.3 Middle East and Africa Point-Of-Care Or Rapid Diagnostics Revenue by Country (2018-2029)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Point-Of-Care Or Rapid Diagnostics Sales by Type (2018-2029)
6.1.1 Global Point-Of-Care Or Rapid Diagnostics Sales by Type (2018-2029) & (K Doses)
6.1.2 Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Type (2018-2029)
6.2 Global Point-Of-Care Or Rapid Diagnostics Revenue by Type (2018-2029)
6.2.1 Global Point-Of-Care Or Rapid Diagnostics Sales by Type (2018-2029) & (US$ Million)
6.2.2 Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Type (2018-2029)
6.3 Global Point-Of-Care Or Rapid Diagnostics Price by Type (2018-2029)
7 Segment by Application
7.1 Global Point-Of-Care Or Rapid Diagnostics Sales by Application (2018-2029)
7.1.1 Global Point-Of-Care Or Rapid Diagnostics Sales by Application (2018-2029) & (K Doses)
7.1.2 Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Application (2018-2029)
7.2 Global Point-Of-Care Or Rapid Diagnostics Revenue by Application (2018-2029)
6.2.1 Global Point-Of-Care Or Rapid Diagnostics Sales by Application (2018-2029) & (US$ Million)
6.2.2 Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Application (2018-2029)
7.3 Global Point-Of-Care Or Rapid Diagnostics Price by Application (2018-2029)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Point-Of-Care Or Rapid Diagnostics Value Chain Analysis
8.1.1 Point-Of-Care Or Rapid Diagnostics Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Point-Of-Care Or Rapid Diagnostics Production Mode & Process
8.2 Point-Of-Care Or Rapid Diagnostics Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Point-Of-Care Or Rapid Diagnostics Distributors
8.2.3 Point-Of-Care Or Rapid Diagnostics Customers
9 Global Point-Of-Care Or Rapid Diagnostics Analyzing Market Dynamics
9.1 Point-Of-Care Or Rapid Diagnostics Industry Trends
9.2 Point-Of-Care Or Rapid Diagnostics Industry Drivers
9.3 Point-Of-Care Or Rapid Diagnostics Industry Opportunities and Challenges
9.4 Point-Of-Care Or Rapid Diagnostics Industry Restraints
10 Report Conclusion
11 Disclaimer
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Point-Of-Care Or Rapid Diagnostics Market Size (2018-2029) & (US$ Million)
2.2.2 Global Point-Of-Care Or Rapid Diagnostics Sales (2018-2029)
2.2.3 Global Point-Of-Care Or Rapid Diagnostics Market Average Price (2018-2029)
2.3 Point-Of-Care Or Rapid Diagnostics by Type
2.3.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 Intensive Care
1.2.3 Covid-19 Testing
1.2.4 Infectious Diseases Testing
1.2.5 Cardiac Markers Testing
1.2.6 Coagulation Testing
1.2.7 Others
2.4 Point-Of-Care Or Rapid Diagnostics by Application
2.4.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
2.4.2 Hospital
2.4.3 Clinic
2.4.4 Independent Laboratories
2.4.5 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Point-Of-Care Or Rapid Diagnostics Market Competitive Situation by Manufacturers (2018 Versus 2022)
3.2 Global Point-Of-Care Or Rapid Diagnostics Sales (K Doses) of Manufacturers (2018-2023)
3.3 Global Point-Of-Care Or Rapid Diagnostics Revenue of Manufacturers (2018-2023)
3.4 Global Point-Of-Care Or Rapid Diagnostics Average Price by Manufacturers (2018-2023)
3.5 Global Point-Of-Care Or Rapid Diagnostics Industry Ranking, 2021 VS 2022 VS 2023
3.6 Global Manufacturers of Point-Of-Care Or Rapid Diagnostics, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Point-Of-Care Or Rapid Diagnostics, Product Type & Application
3.8 Global Manufacturers of Point-Of-Care Or Rapid Diagnostics, Date of Enter into This Industry
3.9 Global Point-Of-Care Or Rapid Diagnostics Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Roche
4.1.1 Roche Company Information
4.1.2 Roche Business Overview
4.1.3 Roche Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
4.1.4 Roche Point-Of-Care Or Rapid Diagnostics Product Portfolio
4.1.5 Roche Recent Developments
4.2 Abbott
4.2.1 Abbott Company Information
4.2.2 Abbott Business Overview
4.2.3 Abbott Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
4.2.4 Abbott Point-Of-Care Or Rapid Diagnostics Product Portfolio
4.2.5 Abbott Recent Developments
4.3 Danaher
4.3.1 Danaher Company Information
4.3.2 Danaher Business Overview
4.3.3 Danaher Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
4.3.4 Danaher Point-Of-Care Or Rapid Diagnostics Product Portfolio
4.3.5 Danaher Recent Developments
4.4 Siemens Healthcare
4.4.1 Siemens Healthcare Company Information
4.4.2 Siemens Healthcare Business Overview
4.4.3 Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
4.4.4 Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Product Portfolio
4.4.5 Siemens Healthcare Recent Developments
4.5 Bio-Rad Laboratories
4.5.1 Bio-Rad Laboratories Company Information
4.5.2 Bio-Rad Laboratories Business Overview
4.5.3 Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.5.5 Bio-Rad Laboratories Recent Developments
4.6 BioMerieux
4.6.1 BioMerieux Company Information
4.6.2 BioMerieux Business Overview
4.6.3 BioMerieux Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
4.6.4 BioMerieux Point-Of-Care Or Rapid Diagnostics Product Portfolio
4.6.5 BioMerieux Recent Developments
4.7 Nova Biomedical
4.7.1 Nova Biomedical Company Information
4.7.2 Nova Biomedical Business Overview
4.7.3 Nova Biomedical Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
4.7.4 Nova Biomedical Point-Of-Care Or Rapid Diagnostics Product Portfolio
4.7.5 Nova Biomedical Recent Developments
6.8 Thermo Fisher Scientific
4.8.1 Thermo Fisher Scientific Company Information
4.8.2 Thermo Fisher Scientific Business Overview
4.8.3 Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
4.8.4 Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Product Portfolio
4.8.5 Thermo Fisher Scientific Recent Developments
4.9 Quidel
4.9.1 Quidel Company Information
4.9.2 Quidel Business Overview
4.9.3 Quidel Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
4.9.4 Quidel Point-Of-Care Or Rapid Diagnostics Product Portfolio
4.9.5 Quidel Recent Developments
4.10 A. Menarini Diagnostics
4.10.1 A. Menarini Diagnostics Company Information
4.10.2 A. Menarini Diagnostics Business Overview
4.10.3 A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
4.10.4 A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Product Portfolio
4.10.5 A. Menarini Diagnostics Recent Developments
6.11 Becton Dickinson
6.11.1 Becton Dickinson Company Information
6.11.2 Becton Dickinson Point-Of-Care Or Rapid Diagnostics Business Overview
6.11.3 Becton Dickinson Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Becton Dickinson Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.11.5 Becton Dickinson Recent Developments
6.12 Biosurfit
6.12.1 Biosurfit Company Information
6.12.2 Biosurfit Point-Of-Care Or Rapid Diagnostics Business Overview
6.12.3 Biosurfit Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Biosurfit Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.12.5 Biosurfit Recent Developments
6.13 Astrego Diagnostics
6.13.1 Astrego Diagnostics Company Information
6.13.2 Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Business Overview
6.13.3 Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.13.5 Astrego Diagnostics Recent Developments
6.14 Werfen
6.14.1 Werfen Company Information
6.14.2 Werfen Point-Of-Care Or Rapid Diagnostics Business Overview
6.14.3 Werfen Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Werfen Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.14.5 Werfen Recent Developments
6.15 Abionic
6.15.1 Abionic Company Information
6.15.2 Abionic Point-Of-Care Or Rapid Diagnostics Business Overview
6.15.3 Abionic Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Abionic Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.15.5 Abionic Recent Developments
6.16 Palex Medical/Bülhmann
6.16.1 Palex Medical/Bülhmann Company Information
6.16.2 Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Business Overview
6.16.3 Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.16.5 Palex Medical/Bülhmann Recent Developments
6.17 Horiba Medical
6.17.1 Horiba Medical Company Information
6.17.2 Horiba Medical Point-Of-Care Or Rapid Diagnostics Business Overview
6.17.3 Horiba Medical Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Horiba Medical Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.17.5 Horiba Medical Recent Developments
6.18 RAL
6.18.1 RAL Company Information
6.18.2 RAL Point-Of-Care Or Rapid Diagnostics Business Overview
6.18.3 RAL Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
6.18.4 RAL Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.18.5 RAL Recent Developments
6.19 Vircell
6.19.1 Vircell Company Information
6.19.2 Vircell Point-Of-Care Or Rapid Diagnostics Business Overview
6.19.3 Vircell Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Vircell Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.19.5 Vircell Recent Developments
6.20 Monlab
6.20.1 Monlab Company Information
6.20.2 Monlab Point-Of-Care Or Rapid Diagnostics Business Overview
6.20.3 Monlab Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Monlab Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.20.5 Monlab Recent Developments
6.21 Binding Site
6.21.1 Binding Site Company Information
6.21.2 Binding Site Point-Of-Care Or Rapid Diagnostics Business Overview
6.21.3 Binding Site Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
6.21.4 Binding Site Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.21.5 Binding Site Recent Developments
5 Global Point-Of-Care Or Rapid Diagnostics Market Scenario by Region
5.1 Global Point-Of-Care Or Rapid Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Point-Of-Care Or Rapid Diagnostics Sales by Region: 2018-2029
5.2.1 Global Point-Of-Care Or Rapid Diagnostics Sales by Region: 2018-2023
5.2.2 Global Point-Of-Care Or Rapid Diagnostics Sales by Region: 2024-2029
5.3 Global Point-Of-Care Or Rapid Diagnostics Revenue by Region: 2018-2029
5.3.1 Global Point-Of-Care Or Rapid Diagnostics Revenue by Region: 2018-2023
5.3.2 Global Point-Of-Care Or Rapid Diagnostics Revenue by Region: 2024-2029
5.4 North America Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Country
5.4.1 North America Point-Of-Care Or Rapid Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
5.4.2 North America Point-Of-Care Or Rapid Diagnostics Sales by Country (2018-2029)
5.4.3 North America Point-Of-Care Or Rapid Diagnostics Revenue by Country (2018-2029)
5.4.4 United States
5.4.5 Canada
5.5 Europe Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Country
5.5.1 Europe Point-Of-Care Or Rapid Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
5.5.2 Europe Point-Of-Care Or Rapid Diagnostics Sales by Country (2018-2029)
5.5.3 Europe Point-Of-Care Or Rapid Diagnostics Revenue by Country (2018-2029)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Country
5.6.1 Asia Pacific Point-Of-Care Or Rapid Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
5.6.2 Asia Pacific Point-Of-Care Or Rapid Diagnostics Sales by Country (2018-2029)
5.6.3 Asia Pacific Point-Of-Care Or Rapid Diagnostics Revenue by Country (2018-2029)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Country
5.7.1 Latin America Point-Of-Care Or Rapid Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
5.7.2 Latin America Point-Of-Care Or Rapid Diagnostics Sales by Country (2018-2029)
5.7.3 Latin America Point-Of-Care Or Rapid Diagnostics Revenue by Country (2018-2029)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Country
5.8.1 Middle East and Africa Point-Of-Care Or Rapid Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
5.8.2 Middle East and Africa Point-Of-Care Or Rapid Diagnostics Sales by Country (2018-2029)
5.8.3 Middle East and Africa Point-Of-Care Or Rapid Diagnostics Revenue by Country (2018-2029)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Point-Of-Care Or Rapid Diagnostics Sales by Type (2018-2029)
6.1.1 Global Point-Of-Care Or Rapid Diagnostics Sales by Type (2018-2029) & (K Doses)
6.1.2 Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Type (2018-2029)
6.2 Global Point-Of-Care Or Rapid Diagnostics Revenue by Type (2018-2029)
6.2.1 Global Point-Of-Care Or Rapid Diagnostics Sales by Type (2018-2029) & (US$ Million)
6.2.2 Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Type (2018-2029)
6.3 Global Point-Of-Care Or Rapid Diagnostics Price by Type (2018-2029)
7 Segment by Application
7.1 Global Point-Of-Care Or Rapid Diagnostics Sales by Application (2018-2029)
7.1.1 Global Point-Of-Care Or Rapid Diagnostics Sales by Application (2018-2029) & (K Doses)
7.1.2 Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Application (2018-2029)
7.2 Global Point-Of-Care Or Rapid Diagnostics Revenue by Application (2018-2029)
6.2.1 Global Point-Of-Care Or Rapid Diagnostics Sales by Application (2018-2029) & (US$ Million)
6.2.2 Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Application (2018-2029)
7.3 Global Point-Of-Care Or Rapid Diagnostics Price by Application (2018-2029)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Point-Of-Care Or Rapid Diagnostics Value Chain Analysis
8.1.1 Point-Of-Care Or Rapid Diagnostics Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Point-Of-Care Or Rapid Diagnostics Production Mode & Process
8.2 Point-Of-Care Or Rapid Diagnostics Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Point-Of-Care Or Rapid Diagnostics Distributors
8.2.3 Point-Of-Care Or Rapid Diagnostics Customers
9 Global Point-Of-Care Or Rapid Diagnostics Analyzing Market Dynamics
9.1 Point-Of-Care Or Rapid Diagnostics Industry Trends
9.2 Point-Of-Care Or Rapid Diagnostics Industry Drivers
9.3 Point-Of-Care Or Rapid Diagnostics Industry Opportunities and Challenges
9.4 Point-Of-Care Or Rapid Diagnostics Industry Restraints
10 Report Conclusion
11 Disclaimer